index,Regulator Name,Regulator Type,Regulator Subtype,Regulator HGNC Symbol,Regulator Database,Regulator ID,Regulator Compartment,Regulator Compartment ID,Regulated Name,Regulated Type,Regulated Subtype,Regulated HGNC Symbol,Regulated Database,Regulated ID,Regulated Compartment,Regulated Compartment ID,Sign,Connection Type,Mechanism,Site,Cell Line,Cell Type,Tissue Type,Organism,Unnamed: 0,Score,Source,Statements,Paper IDs,Evidence Score,Match Score,Kind Score,Epistemic Value,Total Score
98,egfrviii,protein,,egfr,uniprot,p00533,plasma membrane,go:0005886,apoptosis,process,,,fplx,apoptosis,,go:0006915,negative,i,inhibits,,,epithelial-like,,human,['230'],nan,nan,"      the fact that egfr functions one of the most vital factors to promote gliomas has attracted many investigations of egfr inhibitors, aiming to promote apoptosis of cancer cells, or to increase tumor sensitivity to possible adjuvant therapies. however, the successful application of egfr-targeted therapy for the treatment of gbm has proven to be very challenging. many gbm patients do not respond to these therapies and eventually show drug resistance and disease progression [16]. to screen and develop novel inhibitors that target both wild type egfr and egfrviii to impair gbm malignant tumor cell biology could be therapeutically beneficial either as single agents or in combination with other chemotherapy agents in gliomas therapy.",pmc6050662,1,10,5,1,15
